Clinical Trial Update: Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is testing adding chemotherapy or chemo-immunotherapy to standard surgery for advanced head and neck cancers, including HPV-positive or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hypopharyngeal Cancer
• Laryngeal Cancer
• Lip and Oral Cavity Cancer
• Oral Cavity Cancer
• Oropharyngeal Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Status: RECRUITING